The Republican-led Senate rescued funding for PEPFAR in a package of spending cuts last month, but the HIV-prevention program ...

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...

Kennedy Jr. is planning to remove all the members of an advisory panel that determines what cancer screenings and other ...

(Reuters) -Health Secretary Robert F. Kennedy Jr. is planning to remove all the members of an advisory panel that determines ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...

Long-acting lenacapavir has been shown to be a promising option for HIV PrEP and is now recommended globally by WHO, with a ...

European regulators have greenlit a twice-yearly injection to prevent HIV that has been hailed as a game-changer in the ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...

An Idaho judge has issued a preliminary injunction that allows some local immigrants to keep receiving HIV medication under a federal program.

HIV funding cuts. 820 words. 2 photos available. PHOENIX – Ending the spread of HIV in Arizona may become more difficult if ...